These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20877474)

  • 1. AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
    Kent SJ; Cooper DA; Chhi Vun M; Shao Y; Zhang L; Ganguly N; Bela B; Tamashiro H; Ditangco R; Rerks-Ngarm S; Pitisuttithum P; Van Kinh N; Bernstein A; Osmanov S;
    PLoS Med; 2010 Sep; 7(9):e1000331. PubMed ID: 20877474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding research capacity and accelerating AIDS vaccine development in Asia.
    Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
    Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
    Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
    AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.
    Vian T; Koseki S; Feeley FG; Beard J
    BMC Health Serv Res; 2013 Oct; 13():378. PubMed ID: 24088300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.
    Ferrantelli F; Buttò S; Cafaro A; Wahren B; Ensoli B
    Springer Semin Immunopathol; 2006 Nov; 28(3):289-301. PubMed ID: 16983452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grappling with global concerns in the search for an HIV vaccine.
    Grady C
    J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International AIDS Vaccine Initiative.
    Berkley S
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):30-4. PubMed ID: 11364811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 12. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    Global HIV/AIDS Vaccine Enterprise
    PLoS Med; 2005 Feb; 2(2):e25. PubMed ID: 15740411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AIDS vaccines: promises and reality].
    Goudsmit J
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.
    Excler JL; Parks CL; Ackland J; Rees H; Gust ID; Koff WC
    Biologicals; 2010 Jul; 38(4):511-21. PubMed ID: 20537552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S. Military HIV Research Program: successfully integrating HIV vaccine research with prevention, care, and treatment.
    Reilly L
    Mil Med; 2010 Jul; 175(7 Suppl):42-4. PubMed ID: 23634478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical challenges of HIV vaccine trials in less developed nations: conflict and consensus in the international arena.
    Bayer R
    AIDS; 2000 May; 14(8):1051-7. PubMed ID: 10853988
    [No Abstract]   [Full Text] [Related]  

  • 20. The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.
    Council of the Global HIV Vaccine Enterprise
    Nat Med; 2010 Sep; 16(9):981-9. PubMed ID: 20823883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.